glp-1-directed nmda receptor antagonism for obesity treatment Weight Reduction with GLP-1 Agonists and Paths Discontinuation While Maintaining Weight Loss GLP1 Receptor Agonists—Effects beyond Obesity
Description
Common adverse effects include nausea, vomiting, diarrhea, and constipation
Mild redness, itching, or a localised Mounjaro skin rash does not always mean treatment needs to be stopped
A team of researchers led by Dr
Yang K et al
Recap Key Actions To maximize muscle preservation while losing weight with GLP-1 therapy, the core recommendations are: Strength Train Consistently: Engage in strength training exercises targeting all major muscle groups 2-3 times per week on non-consecutive days
